Neurones S.A (NRO) | Stock Overview & Key Data
Neurones S.A. | Large-cap | Technology
Neurones S.A. | Large-cap | Technology
Neurones S.A Performance Comparison
Stock Range
Today's Range
Low: €41.65
High: €42.75
on August 8, 2025
52 Week Range
Low: €41.10
High: €52.00
on September 18, 2024
on March 3, 2025
All-Time High: €52.00 on March 3, 2025
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€1.1B
EPS
2.16
P/E Ratio (TTM)
20.07
Forward P/E
19.70
P/B Ratio
2.78
PEG Ratio
19.70
Div. Yield
2.76%
ROE
14.95%
Beta
0.560
Debt to Equity
9.63
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
10.01%
Profit Margin
6.49%
Returns and Earnings
Return on Assets (TTM)
6.94%
Return on Equity (TTM)
14.95%
EBITDA
€107.3M
Net Income (TTM)
€52.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€33.38
Quarterly Revenue Growth (YoY)
9.50%
Quarterly Earnings Growth (YoY)
17.00%
Dividend Information
Last 12-Month Dividend
€1.30
Current Dividend Yield
2.76%
3-Year Average Dividend Yield
2.76%
3-Year Average Annual Dividend
€1.20
3-Year Total Dividends
€3.60
Ex-Dividend Date
June 11, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Neurones S.A NRO | 1.05B Large-cap | -0.47% | -5.78% | -10.17% | -10.36% | -3.85% | 1.19% | 7.75% | 73.06% |
| Capgemini SE CAP | 21.51B Large-cap | 0.92% | -12.20% | -13.11% | -28.94% | -19.82% | -28.74% | -33.21% | 12.80% |
| Sopra Steria SOP | 3.55B Large-cap | 0.38% | -9.91% | -3.06% | 3.61% | 8.83% | 10.14% | 17.02% | 37.94% |
| Alten S.A ATE | 2.45B Large-cap | 2.02% | -9.53% | -3.74% | -18.91% | -10.22% | -26.72% | -47.59% | 3.97% |
| Wavestone S.A WAVE | 1.42B Large-cap | 3.01% | -0.51% | 17.81% | 16.17% | 35.35% | 12.14% | 13.89% | 191.00% |
| Aubay Société AUB | 661.61M Mid-cap | 2.04% | -1.96% | 10.62% | 10.01% | 9.89% | 41.24% | -8.09% | 54.80% |
Ownership & Short Interest
Insider Ownership
69.64%
Institutional Ownership
14.04%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
9K
Average 90-Day Volume
7K
Neurones S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Neurones S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NRO's 52-week high and low?
- In the last 52 weeks, Neurones S.A reached a high of €52.00 (on March 3, 2025) and a low of €41.10 (on September 18, 2024).
- What is the market cap and P/E ratio for NRO?
- Curious about Neurones S.A's size and valuation? Its market capitalization stands at 1.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 20.07, and the forward P/E (looking ahead) is 19.70.
- Does NRO pay dividends? If so, what's the yield?
- Yes, Neurones S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.76%, and the company has paid an average of €1.20 per share annually over the past 3 years.
- Who are Neurones S.A's main competitors or similar companies to consider before investing?
When looking at Neurones S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Capgemini SE
CAP21.51B Technology Information Technology Services -28.74% -33.21% Sopra Steria
SOP3.55B Technology Information Technology Services 10.14% 17.02% Alten S.A
ATE2.45B Technology Information Technology Services -26.72% -47.59% Wavestone S.A
WAVE1.42B Technology Information Technology Services 12.14% 13.89% Aubay Société
AUB661.61M Technology Information Technology Services 41.24% -8.09% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Neurones S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Neurones S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.95%, the Debt to Equity ratio from the most recent quarter is 9.63, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NRO?
- Looking at Neurones S.A's growth, its revenue over the trailing twelve months (TTM) was €810M. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.50%, and quarterly earnings saw a YoY growth of 17.00%.
- How much of NRO stock is held by insiders and institutions?
- Wondering who owns Neurones S.A stock? Company insiders (like executives and directors) hold about 69.64% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 14.04%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.